AzTrials
AzTrials

Cognitive DeclineMATNCT06152614

MIND Foods and Aerobic Training in Black Adults With HTN

A study testing Food Delivery and Cooking PLUS Aerobic Training (FoRKS+) in people with Cognitive Decline and Hypertension, run by Indiana University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this randomized controlled trial is to determine the impact of Mediterranean-Dash Intervention for Neurodegenerative Delay (MIND) diet and aerobic training on cognition in Black adults with high systolic blood pressure. Read more about this study

Who is it for?
Ages 35 to 75 years
Conditions the study is for
Cognitive Decline, Hypertension, Diet
What is being tested?
Food Delivery and Cooking PLUS Aerobic Training (FoRKS+)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
128 participants
Where
1 siteUnited States
Study dates
28 Nov 2023to 31 May 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Fluent in English
  • Marion County resident
  • 35-75 years
  • Self-identified non-Hispanic and Black/African-American/biracial including African-American
  • Systolic BP of ≥140 in prior 12 months from a primary care visit
  • Ability to see and read street signs (self report)
Show all 12Show fewer
  • Stable housing with independent access to kitchen, including functional stove or hotplate, oven, refrigerator, and freezer (self report)
  • Activity independence per functional activities questionnaire (FAQ; <3 responses of "Require Assistance" and 0 responses of "Dependent")
  • Normal cognition per six-item screener (SIS; score of ≥ 5)
  • Less than 20min on usual day of moderate or vigorous physical activity
  • Able to exercise safely per abbreviated Exercise Assessment for You (EASY) or primary care provider clearance
  • Mean systolic BP of ≥130 from 3 standard BP measurements taken by research staff following standardized wait periods.

Who cannot join

  • lives in nursing home
  • diagnosis of dementia or Alzheimer disease or mild cognitive impairment; Parkinson disease; brain tumor/infection/surgery (within the last 10 years with residual symptoms and/or functional loss/deficit, such as impaired learning, memory, or communication); cancer with short life expectancy, or current chemotherapy or radiation therapy; psychosis, schizophrenia, or bipolar disorder
  • ICD 10 code I11/hypertensive heart disease, ICD 10 code I12/hypertensive CKD, ICD 10 code I13/hypertensive heart disease and CKD, ICD 10 code I15, or ICD 10 code I16
  • current or past prescription of donepezil, memantine, rivastigmine, or galantamine
  • alcohol consumption ≥ 8 drinks per week for women, or ≥15 drinks per week for men
  • drug use/abuse (excluding marijuana) per EMR
Show all 13Show fewer
  • moving out of area during study timeline
  • scheduling conflicts with intervention schedule
  • unwilling to use a touchscreen
  • unwilling to be on video conferencing
  • low communicative ability, functional status, or other disorders (examiner rated) that would interfere with interventions and assessments
  • unable to provide informed consent
  • participation in any lifestyle modification/weight loss program (e.g., Weight Watchers, etc.)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Daniel O Clark, PhD contact

317-274-9292

daniclar@iu.edu

Lyndsi R Moser, BA, CCRP contact

317-278-7727

lrhabegg@iu.edu

United States1 site, 1 recruiting
  • Eskenazi Health

    Indianapolis, Indiana, 46202

    Recruiting

Other trials in United States

About this study

Official title: MIND Foods and Aerobic Training in Black Adults With HTN: An ADRD Prevention Pilot RCT

The goal of this randomized controlled trial is to determine the impact of Mediterranean-Dash Intervention for Neurodegenerative Delay (MIND) diet and aerobic training on cognition in Black adults with high systolic blood pressure.

Researchers will compare Food Delivery and Cooking PLUS Aerobic Training (FoRKS+) versus Enhanced Usual Care (EUC) to evaluate the effects on cognition.

Read more

Participants will complete cognitive and cardiovascular assessments, 24-hr blood pressure monitoring, standard blood pressure measurements, weight, fingerstick for HbA1c point-of-care testing, and questionnaires.

Participants may also choose to participate in an optional blood draw for DNA Repair Capacity testing as a modifiable risk factor for aging-associated diseases.

Read the detailed description

This randomized controlled trial will evaluate Mediterranean-Dash Intervention for Neurodegenerative Delay (MIND) diet and aerobic training (FoRKS+) versus enhanced usual care (EUC) in Black adults with systolic blood pressure of ≥140 mm Hg. This project seeks to evaluate the potential for high-polyphenol nutritious foods, hands-on training in food management skills, and aerobic exercise to impact cognition and risk factor reduction in persons with prevalent chronic disease.

Adults who pass the telephone screen will be invited to complete a blood pressure check for final eligibility determination. Participants must receive an average systolic read of ≥130 mmHG across 3 standard BP readings with designated wait periods; a maximum of 5 readings may be attempted to receive 3 successful measurements necessary to calculate the average. Participants who meet criteria and give informed consent will complete a full baseline assessment, consisting of cognitive and cardiovascular assessments, blood pressure, weight, HbA1c testing, questionnaires, 24-hour ambulatory blood pressure and optional blood draw.

Participants will be randomized to one of two arms:

Enhanced Usual Care (EUC), consisting of access to existing usual primary care services such as social determinants of health screenings, referrals to food pantries, and assistance enrolling in food assistance programs. They will be enrolled in a 5-week Hypertension Self-Management Education and Support (SMES) class, which is an existing CDC-endorsed program offered at Eskenazi to provide information and skills for managing hypertension (HTN).

Food Delivery and Cooking PLUS Aerobic Training (FoRKS+), consisting of the same services as EUC plus home-delivered MIND diet ingredient kits and virtual cooking classes for an additional 11 weeks with embedded lessons in kitchen organization, tool use, nutrition, budgeting, and shopping; PLUS aerobic training for an additional 12 weeks of moderate-intensity exercise.

Assessments will be completed at mid-intervention around Week 16, Week 28 as the primary endpoint, and around Week 52 for maintenance evaluation.

Being tested
Enhanced Usual Care (EUC), Food Delivery and Cooking PLUS Aerobic Training (FoRKS+)
Keywords
nutrition, cooking, exercise, hypertension
Medical subject headings
Cognitive Dysfunction, Hypertension, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Enhanced Usual Care (EUC)Behavioural

    Enhanced Usual Care (EUC) includes 5 weeks of hypertension classes.

  • Food Delivery and Cooking PLUS Aerobic Training (FoRKS+)Behavioural

    Food Delivery and Cooking PLUS Aerobic Training (FoRKS+) includes 5 weeks of hypertension classes followed by 11 weeks of home-delivered Mediterranean-style ingredient kits and virtual cooking classes, and an additional 12 weeks of aerobic exercise.

Study groups in NCT06152614
Study groupRoleWhat they receive
Enhanced Usual Care (EUC)Active comparatorParticipants randomized to EUC will have access to existing usual primary care services. They will also be enrolled in Hypertension Self-Management Education and Support (SMES) class ("Hypertension group"), which is an existing CDC-endorsed program offered at Eskenazi Health to provide information and skills for managing hypertension (HTN). Classes are led by registered dietitians via Webex.
Receives: Behavioral: Enhanced Usual Care (EUC)
Food Delivery and Cooking PLUS Aerobic Training (FoRKS+)ExperimentalParticipants randomized to FoRKS+ will attend weekly HTN SMES classes separately from EUC participants. SMES classes will include the EUC curriculum stated above and an introduction to the upcoming FoRKS+ intervention. Following HTN SMES completion, FoRKS+ continues with home-delivered Mediterranean-style ingredient kits, food management lessons, and hands-on cooking classes in one's own kitchen. Classes are led by registered dietitians via Webex. Classes are held twice per week thru Week 12, then only once per week through Week 16. Intervention continues with aerobic exercise led by health coaches via Webex. Classes start in Week 13 with one session per week, increasing to two sessions per week in Weeks 17-28.
Receives: Behavioral: Food Delivery and Cooking PLUS Aerobic Training (FoRKS+)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cognitive function composite score as measured by individually-administered tests of psychomotor speed, complex sequencing, semantic fluency, interference and list learning and delayed recall at Week 28.

    The cognitive composite is derived from WAIS-IV Symbol Search \& Coding, Trail Making Test Part B, Animals-Vegetables-Clothing Naming, Stroop Color-Word, and RBANS Update List Learning and List Recall. The composite will be formed by standardizing each test raw score to the sample baseline mean and standard deviation and then taking an average of the resultant z-scores. These measures will be combined into a single, overall cognitive composite score.

    Measured: Week 28 post intervention start date

  2. Cognitive function composite score as measured by individually-administered tests of psychomotor speed, complex sequencing, semantic fluency, interference and list learning and delayed recall at Week 52.

    The cognitive composite is derived from WAIS-IV Symbol Search \& Coding, Trail Making Test Part B, Animals-Vegetables-Clothing Naming, Stroop Color-Word, and RBANS Update List Learning and List Recall. The composite will be formed by standardizing each test raw score to the sample baseline mean and standard deviation and then taking an average of the resultant z-scores. These measures will be combined into a single, overall cognitive composite score.

    Measured: Week 52 post intervention start date

Secondary outcomes (4)
  1. Average participant self-ratings of intervention acceptability.

    Average of individual Likert self-ratings of the interventions (where 1 = very unenjoyable, 2 = not enjoyable, 3 = neutral, 4 = enjoyable, and 5 = very enjoyable) throughout the 28-week intervention.

    Measured: From date of randomization until the date of the final training session or the end of the 28-week intervention, whichever came first.

  2. Participant adherence to treatment.

    Number of training sessions attended divided by the the total number of sessions available.

    Measured: From date of randomization until the date of the final training session or the end of the 28-week intervention, whichever came first.

  3. Participant adherence to outcome assessments.

    Number of participants completing the outcome assessments divided by the total number randomized.

    Measured: End of follow-up at 52-weeks.

  4. Number of participants with study-related adverse events (AE) by treatment arm.

    Adverse event count for each study arm

    Measured: From enrollment through end of follow-up at 52-weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Nov 2023
  2. Study start28 Nov 2023
  3. Primary completion31 May 2028 (estimated)
  4. Study completion31 May 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
128 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06152614
Sponsor's protocol ID
16547
Other IDs
R01AG076685
Acronym
MAT
Status last verified
Jul 2026
First submitted
2 Nov 2023
Last updated
22 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Food Delivery and Cooking PLUS Aerobic Training (FoRKS+) in people with Cognitive Decline and Hypertension, run by Indiana University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Daniel O Clark, PhD (317-274-9292, daniclar@iu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cognitive function composite score as measured by individually-administered tests of psychomotor speed, complex sequencing, semantic fluency, interference and list learning and delayed recall at Week 28. (time frame: Week 28 post intervention start date). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in